Antimicrobial Resistance Research Assessment Act of 2024

The Comptroller General of the United States shall—

(1) prepare a report on efforts of the Federal Government to address antimicrobial resistance; and

(2) not later than 1 year after the date of enactment of this Act—

(A) finalize such report; and

(B) submit such report to the Congress.

The report required by subsection (a) shall—

(1) address all efforts of the Federal Government regarding antimicrobial resistance, including any such efforts involving—

(A) establishing, maintaining, or operating a task force, committee, or interagency program; or

(B) developing a plan or report;

(2) specify the role of each Federal program and resource in such efforts;

(3) identify any such efforts that are duplicative;

(4) recommend ways to improve the coordination of such efforts across the Federal Government;

(5) identify the results achieved thus far through such efforts;

(6) describe any such efforts related to phage therapy; and

(7) with respect to research being federally conducted or supported with respect to antimicrobial resistance—

(A) quantify of the costs of such research;

(B) if any such research is identified as duplicative pursuant to paragraph (3), recommend approaches for coordinating or consolidating such research to avoid duplication; and

(C) recommend whether there should be a central Federal agency to oversee such research.